Nutra Pharma Corp. (NPHC)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Nov 6, 2026
Nutra Pharma Revenue
Nutra Pharma had revenue of $57.92K in the quarter ending June 30, 2026, a decrease of -52.58%. This brings the company's total for the last twelve months to $258.91K, down -44.15% year-over-year. In the year 2025, Nutra Pharma had annual revenue of $385.31K, down -1.74%. That makes Nutra Pharma the 45,273rd largest company in the world by revenue and 6,556th in the United States.
Revenue (ttm)
258.91K
Revenue Growth
-44.15%
P/S Ratio
2.77
Revenue / Employee
43.15K
Employees
6
Market Cap
715.97K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 385.31K | -6.84K | -1.74% |
| Dec 31, 2024 | 392.15K | -202.73K | -34.08% |
| Dec 31, 2023 | 594.88K | 156.61K | 35.73% |
| Dec 31, 2022 | 438.27K | 340.54K | 348.43% |
| Dec 31, 2021 | 97.74K | 45.84K | 88.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Target Group | 3.50M |
| CannaPharmaRX | 1.70M |
| LiveWire Ergogenics | 571.68K |
| Herborium Group | 259.10K |
| Anything Technologies Media | 257.70K |
| Demand Brands | 165.00K |
| TransGlobal Assets | 91.35K |
| Kaya Holdings | 26.69K |